Page last updated: 2024-11-06

gentisamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Gentisamide is a synthetic compound derived from gentisic acid, a natural phenolic compound found in plants. It exhibits a range of pharmacological properties, including anti-inflammatory, antioxidant, and antimicrobial activities. Notably, gentisamide has shown promising results in preclinical studies for its potential therapeutic applications in various diseases, such as cancer, Alzheimer's disease, and diabetes. Its mechanism of action is believed to involve the inhibition of specific enzymes and signaling pathways involved in disease pathogenesis. The compound's synthesis typically involves a multi-step process, starting with the modification of gentisic acid. Its therapeutic potential has led to ongoing research efforts focused on further exploring its effects, optimizing its delivery methods, and investigating its safety and efficacy in human clinical trials.'

gentisamide: metabolite of salicylamides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID72877
CHEMBL ID3629433
SCHEMBL ID1163541
MeSH IDM0157052

Synonyms (17)

Synonym
einecs 257-895-8
5-hydroxysalicylamide
brn 2640803
benzamide, 2,5-dihydroxy-
2,5-dihydroxybenzamide
52405-73-9
gentisamide
salicylamide, 5-hydroxy-
AKOS006273163
rp2mfx432p ,
unii-rp2mfx432p
SCHEMBL1163541
2,5-dihydroxy benzamide
FRXZIFVYTNMCHF-UHFFFAOYSA-N
CHEMBL3629433
DTXSID60200423
gentisicamide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" However, in the present study, 18% of the salicylamide metabolites appearing in urine after either dosage of salicylamide were 3-hydroxylation products."( 3-Hydroxylation of salicylamide in mice.
Dills, RL; Howell, SR; Klaassen, CD; Kotkoskie, LA, 1988
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1252320Antioxidant activity assessed as DPPH free radical scavenging activity at 0.01 to 1 mM after 30 mins2015Bioorganic & medicinal chemistry letters, Nov-01, Volume: 25, Issue:21
The antioxidant properties of salicylate derivatives: A possible new mechanism of anti-inflammatory activity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (44.44)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]